Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. / McLaughlin, Tracey; Peck, Marcia; Holst, Jens; Deacon, Carolyn.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 95, No. 4, 04.2010, p. 1851-5.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

McLaughlin, T, Peck, M, Holst, J & Deacon, C 2010, 'Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery', Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 4, pp. 1851-5. https://doi.org/10.1210/jc.2009-1628

APA

McLaughlin, T., Peck, M., Holst, J., & Deacon, C. (2010). Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. Journal of Clinical Endocrinology and Metabolism, 95(4), 1851-5. https://doi.org/10.1210/jc.2009-1628

Vancouver

McLaughlin T, Peck M, Holst J, Deacon C. Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. Journal of Clinical Endocrinology and Metabolism. 2010 Apr;95(4):1851-5. https://doi.org/10.1210/jc.2009-1628

Author

McLaughlin, Tracey ; Peck, Marcia ; Holst, Jens ; Deacon, Carolyn. / Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. In: Journal of Clinical Endocrinology and Metabolism. 2010 ; Vol. 95, No. 4. pp. 1851-5.

Bibtex

@article{bf27241249ff4952ad71030e0dbf9c93,
title = "Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery",
abstract = "Severe hypoglycemia after Roux-en-Y gastric bypass surgery (RYGB) is an increasingly recognized condition, characterized by neuroglycopenia and inappropriately elevated insulin concentrations that occur primarily in the postprandial state. Both pathophysiology and treatment of this disorder remain elusive, but it has been postulated that hyperplasia and/or hypertrophy of beta-cells due to morbid obesity and/or postsurgical nesidioblastosis may contribute.",
keywords = "Adult, Blood Glucose, Body Mass Index, Female, Gastric Bypass, Gastric Inhibitory Polypeptide, Glucagon, Glucagon-Like Peptide 1, Humans, Hyperinsulinism, Hypoglycemia, Insulin, Nutritional Status, Obesity, Morbid, Postoperative Complications",
author = "Tracey McLaughlin and Marcia Peck and Jens Holst and Carolyn Deacon",
year = "2010",
month = apr,
doi = "10.1210/jc.2009-1628",
language = "English",
volume = "95",
pages = "1851--5",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Oxford University Press",
number = "4",

}

RIS

TY - JOUR

T1 - Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery

AU - McLaughlin, Tracey

AU - Peck, Marcia

AU - Holst, Jens

AU - Deacon, Carolyn

PY - 2010/4

Y1 - 2010/4

N2 - Severe hypoglycemia after Roux-en-Y gastric bypass surgery (RYGB) is an increasingly recognized condition, characterized by neuroglycopenia and inappropriately elevated insulin concentrations that occur primarily in the postprandial state. Both pathophysiology and treatment of this disorder remain elusive, but it has been postulated that hyperplasia and/or hypertrophy of beta-cells due to morbid obesity and/or postsurgical nesidioblastosis may contribute.

AB - Severe hypoglycemia after Roux-en-Y gastric bypass surgery (RYGB) is an increasingly recognized condition, characterized by neuroglycopenia and inappropriately elevated insulin concentrations that occur primarily in the postprandial state. Both pathophysiology and treatment of this disorder remain elusive, but it has been postulated that hyperplasia and/or hypertrophy of beta-cells due to morbid obesity and/or postsurgical nesidioblastosis may contribute.

KW - Adult

KW - Blood Glucose

KW - Body Mass Index

KW - Female

KW - Gastric Bypass

KW - Gastric Inhibitory Polypeptide

KW - Glucagon

KW - Glucagon-Like Peptide 1

KW - Humans

KW - Hyperinsulinism

KW - Hypoglycemia

KW - Insulin

KW - Nutritional Status

KW - Obesity, Morbid

KW - Postoperative Complications

U2 - 10.1210/jc.2009-1628

DO - 10.1210/jc.2009-1628

M3 - Journal article

C2 - 20133462

VL - 95

SP - 1851

EP - 1855

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -

ID: 32437001